mergers and acquisitions
The AI brokerage company, which launched in January with $60 million in funding, announced its acquisition of Medicare brokerage agency Avid Health earlier this month.
The acquisition will enable Stryker to expand its portfolio with intravascular lithotripsy technology from Amplitude Vascular Systems for treating severely calcified arteries.
The deal will combine digital engagement tools and on-site clinical services to help employers and health plans better manage risk and support employee health.
The acquisition allows Cerebral to offer ADHD patients ongoing support through therapy, skill-building modules, medication management and community engagement.
The company acquired Intelerad for $2.3 billion in cash and debt financing and expects around $270 million in recurring annual revenue and a high-single-digit return on investment within five years.
The Helsinki‑based company offers AI-enabled biometric and gesture recognition technology that allows for device control with natural movements.
Following the acquisition, April Koh will continue as CEO to lead Spring Health and Harry Ritter will remain CEO of Alma as the brands operate separately.
The acquisition allows Sword to scale its presence in the U.S. and bring its physical therapy platform to the German market.
AION Labs CEO sat down with MobiHealthNews outside the JPM Healthcare Conference to discuss the acquisition he says represents a milestone for Israel’s biotech ecosystem.
Applied Tissue Technologies’ NPWT device and micrografting kit will be added to New Horizon Medical Solutions' portfolio, expanding the company's wound care offerings.